In the first half of 2022, roughly 22 percent of cancer drugs acquired via public procurement in Russia originated in Switzerland. Ranking second and third were Russia and the United States, accounting for approximately a quarter of the cancer medication market each.
Distribution of the oncology drug revenue acquired via public procurement in Russia in 1st half 2022, by product origin
Public procurement is a process by which a government purchases goods from the private sector to meet state and municipal needs whilst paying from budgetary or non-budgetary funds.
Only the nine leading countries of origin were presented.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Vmeste Protiv Raka. (August 4, 2022). Distribution of the oncology drug revenue acquired via public procurement in Russia in 1st half 2022, by product origin [Graph]. In Statista. Retrieved October 31, 2024, from https://www.statista.com/statistics/1385976/russia-cancer-drug-market-share-by-origin/
Vmeste Protiv Raka. "Distribution of the oncology drug revenue acquired via public procurement in Russia in 1st half 2022, by product origin." Chart. August 4, 2022. Statista. Accessed October 31, 2024. https://www.statista.com/statistics/1385976/russia-cancer-drug-market-share-by-origin/
Vmeste Protiv Raka. (2022). Distribution of the oncology drug revenue acquired via public procurement in Russia in 1st half 2022, by product origin. Statista. Statista Inc.. Accessed: October 31, 2024. https://www.statista.com/statistics/1385976/russia-cancer-drug-market-share-by-origin/
Vmeste Protiv Raka. "Distribution of The Oncology Drug Revenue Acquired via Public Procurement in Russia in 1st Half 2022, by Product Origin." Statista, Statista Inc., 4 Aug 2022, https://www.statista.com/statistics/1385976/russia-cancer-drug-market-share-by-origin/
Vmeste Protiv Raka, Distribution of the oncology drug revenue acquired via public procurement in Russia in 1st half 2022, by product origin Statista, https://www.statista.com/statistics/1385976/russia-cancer-drug-market-share-by-origin/ (last visited October 31, 2024)
Distribution of the oncology drug revenue acquired via public procurement in Russia in 1st half 2022, by product origin [Graph], Vmeste Protiv Raka, August 4, 2022. [Online]. Available: https://www.statista.com/statistics/1385976/russia-cancer-drug-market-share-by-origin/
